Early cytokine signatures and clinical phenotypes discriminate persistent from resolving MRSA bacteremia

By sjmartinez • February 19, 2025

Bergersen KV, Zheng Y, Rossetti M, Ruffin F, Pickering H, Parmar R, Sunga G, Chan LC, Gjertson D, Fowler VG, Yeaman MR, Reed EF; MRSA Systems Immunobiology Group. Early cytokine signatures and clinical phenotypes discriminate persistent from resolving MRSA bacteremia. BMC Infect Dis. 2025 Feb 18;25(1):231. doi: 10.1186/s12879-025-10620-3. PMID: 39966757.

Tags: Clinical phenotypes, Cytokine signatures, Harbor UCLA, MRSA, persistence, Publications, Pulmonary, Critical Care & Sleep Medicine, Staphylococcus aureus

Implementation of a seamless phase 2/3 study design in the setting of an emergent infectious disease pandemic: Lessons learned from the ACTIV-2 platform COVID-19 treatment trial

Giganti MJ, Chew KW, Moser C, Eron JJ, Pinilla M, Li JZ, Ritz J, Javan AC, Wohl DA, Daar ES, Currier JS, Smith DM, Hughes[...]

Expert Discussion on Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Challenges and Considerations

Lafayette RA, Charu V, Glassock RJ. Expert Discussion on Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Challenges and Considerations. Adv Ther. 2025 Mar 27. doi: 10.1007/s12325-025-03167-x. Epub ahead[...]

Association of Extracoronary Calcification and Incident Heart Failure in the Multiethnic Study of Atherosclerosis (MESA)

Brar S, Goli R, Barrios JP, Blaha MJ, Kianoush S, Pletcher MJ, Nomura SO, Tsai MY, Duan R, Budoff MJ, Szklo M, Tison GH. Association[...]